Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2016
Genomic Characterization of Primary Invasive Lobular Breast Cancer
Christine Desmedt, Gabriele Zoppoli, Gunes Gundem, et al.
The Journal of Pathology
|
April 9, 2015
Uncovering the genomic heterogeneity of multifocal breast cancer
Christine Desmedt, Debora Fumagalli, Elisabetta Pietri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2021
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up
Martine Piccart, Marion Procter, Debora Fumagalli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 16, 2022
Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant
Luca Malorni, Svitlana Tyekucheva, Florentine S Hilbers, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 25, 2021
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)
Alvaro Moreno-Aspitia, Eileen M Holmes, Christian Jackisch, et al.
Journal of the National Cancer Institute
|
November 23, 2013
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31
Katherine L Pogue-Geile, Chungyeul Kim, Jong-Hyeon Jeong, et al.
The Lancet. Oncology
|
March 15, 2021
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
Martine Piccart, Laura J van 't Veer, Coralie Poncet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 23, 2018
Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data
Dimitrios Zardavas, Luc Te Marvelde, Roger L Milne, et al.
The New England Journal of Medicine
|
June 3, 2021
Adjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer
Andrew N J Tutt, Judy E Garber, Bella Kaufman, et al.
The Lancet. Oncology
|
January 18, 2021
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
Erica L Mayer, Amylou C Dueck, Miguel Martin, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2016
Genomic Characterization of Primary Invasive Lobular Breast Cancer
Christine Desmedt, Gabriele Zoppoli, Gunes Gundem, et al.
The Journal of Pathology
|
April 9, 2015
Uncovering the genomic heterogeneity of multifocal breast cancer
Christine Desmedt, Debora Fumagalli, Elisabetta Pietri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2021
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up
Martine Piccart, Marion Procter, Debora Fumagalli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 16, 2022
Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant
Luca Malorni, Svitlana Tyekucheva, Florentine S Hilbers, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 25, 2021
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)
Alvaro Moreno-Aspitia, Eileen M Holmes, Christian Jackisch, et al.
Journal of the National Cancer Institute
|
November 23, 2013
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31
Katherine L Pogue-Geile, Chungyeul Kim, Jong-Hyeon Jeong, et al.
The Lancet. Oncology
|
March 15, 2021
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
Martine Piccart, Laura J van 't Veer, Coralie Poncet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 23, 2018
Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data
Dimitrios Zardavas, Luc Te Marvelde, Roger L Milne, et al.
The New England Journal of Medicine
|
June 3, 2021
Adjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer
Andrew N J Tutt, Judy E Garber, Bella Kaufman, et al.
The Lancet. Oncology
|
January 18, 2021
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
Erica L Mayer, Amylou C Dueck, Miguel Martin, et al.
Page
of 7